Brainsway Ltd. (BWAY) Announces Data from Feasibility Study of Deep Transcranial Magnetic Stimulation System in the treatment of Adults with ADHD

0
15

February 10, 2020 9:07 AM EST



Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

BrainsWay Ltd. (NASDAQ: BWAY) (“BrainsWay”) today announced results from a randomized controlled double-blind clinical trial (NCT01196910) assessing the safety and efficacy of the Company’s proprietary H6-coil deep transcranial magnetic stimulation (dTMS) System for the treatment of adults with attention deficit hyperactivity disorder (ADHD). Researchers at Tel Aviv Sourasky Medical Center, Tel Aviv University, Ben Gurion University and BrainsWay conducted the study, which used functional magnetic resonance imaging (fMRI) to assess the effect of dTMS on clinical, cognitive and neural activity in adults with ADHD. Results showed a statistically significant improvement in patient-reported assessments of inattention, together with a significant increase in activity that was observed within the dorsolateral prefrontal cortex (DLPFC), a brain area previously shown to express reduced activity in adults with ADHD.

“Reduced activity of the DLPFC, a brain region that controls the ability to respond to changing attentional demands, has previously been observed in patients with ADHD,” said Dr. Maya Bleich-Cohen, senior investigator at Tel Aviv Sourasky Medical Center and an investigator on the study. “The results of this initial study indicate that dTMS can be effective in modulating the DLPFC and that this may be a feasible technique to improve attention symptoms in adults with ADHD. Additional study of this non-invasive treatment approach in this population is warranted.”


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In


// Additional initialization code here FB.Event.subscribe('auth.statusChange', function(response) { if ( response.status == 'connected' ) { if ( window.fbLoginCallback ) { window.fbLoginCallback.call(window, response); } } });

FB.Event.subscribe('edge.create', function(e) { if ( window.onFbLike ) { window.onFbLike(); } }); };

// Load the SDK Asynchronously (function(d){ var js, id = 'facebook-jssdk', ref = d.getElementsByTagName('script')[0]; if (d.getElementById(id)) {return;} js = d.createElement('script'); js.id = id; js.async = true; js.src = "http://connect.facebook.net/en_US/all.js"; ref.parentNode.insertBefore(js, ref); }(document));

fbq('init', '426630107544656'); fbq('track', "PageView");

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here